- Home
- TLSI vs EUDA Comparison
TLSI vs EUDA Comparison
Compare TLSI & EUDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- EUDA
- Stock Information
- Founded
- TLSI 2010
- EUDA 2021
- Country
- TLSI United States
- EUDA Singapore
- Employees
- TLSI N/A
- EUDA N/A
- Industry
- TLSI Medical Specialities
- EUDA Blank Checks
- Sector
- TLSI Health Care
- EUDA Finance
- Exchange
- TLSI Nasdaq
- EUDA Nasdaq
- Market Cap
- TLSI 166.8M
- EUDA 159.1M
- IPO Year
- TLSI N/A
- EUDA N/A
- Fundamental
- Price
- TLSI $4.83
- EUDA $3.84
- Analyst Decision
- TLSI Strong Buy
- EUDA
- Analyst Count
- TLSI 2
- EUDA 0
- Target Price
- TLSI $14.00
- EUDA N/A
- AVG Volume (30 Days)
- TLSI 69.8K
- EUDA 53.5K
- Earning Date
- TLSI 08-14-2024
- EUDA 09-24-2024
- Dividend Yield
- TLSI N/A
- EUDA N/A
- EPS Growth
- TLSI N/A
- EUDA N/A
- EPS
- TLSI N/A
- EUDA N/A
- Revenue
- TLSI $24,736,000.00
- EUDA $3,706,458.00
- Revenue This Year
- TLSI $61.24
- EUDA N/A
- Revenue Next Year
- TLSI $47.32
- EUDA N/A
- P/E Ratio
- TLSI N/A
- EUDA N/A
- Revenue Growth
- TLSI 67.75
- EUDA N/A
- 52 Week Low
- TLSI $3.32
- EUDA $0.60
- 52 Week High
- TLSI $10.42
- EUDA $4.97
- Technical
- Relative Strength Index (RSI)
- TLSI 36.52
- EUDA 45.10
- Support Level
- TLSI $4.80
- EUDA $3.64
- Resistance Level
- TLSI $5.32
- EUDA $3.91
- Average True Range (ATR)
- TLSI 0.34
- EUDA 0.33
- MACD
- TLSI -0.02
- EUDA -0.11
- Stochastic Oscillator
- TLSI 3.06
- EUDA 41.46
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About EUDA EUDA Health Holdings Limited
EUDA Health Holdings Ltd is a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem aimed at making healthcare affordable and accessible, The company's proprietary unified AI platform quickly assesses a patient's medical history, triages a condition, digitally connects patients with clinicians, and predicts optimal treatment outcomes. The company caters to all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and aftercare services. The company operates in two segments namely Medical services and property management services, out of which the company derives its maximum revenue from Medical services.